选择性雌激素受体调节剂研究现状

乳腺癌已经成为危害女性健康的主要恶性肿瘤,选择性雌激素受体调节剂作为治疗乳腺癌的有效药物越来越受到人们的广泛关注。笔者对选择性雌激素受体调节剂的研究现状进行综述。

Saved in:
Bibliographic Details
Published in药学实践杂志 Vol. 34; no. 1; pp. 1 - 4
Main Author 丁浩 杨帆 蔡艺 柴晓云 吴秋业
Format Journal Article
LanguageChinese
Published 第二军医大学药学院有机化学教研室,上海,200433%第二军医大学药学院有机化学教研室,上海 200433 2016
烟台大学药学院,山东烟台264005
Subjects
Online AccessGet full text
ISSN1006-0111
DOI10.3969/j.issn.1006-0111.2016.01.001

Cover

More Information
Summary:乳腺癌已经成为危害女性健康的主要恶性肿瘤,选择性雌激素受体调节剂作为治疗乳腺癌的有效药物越来越受到人们的广泛关注。笔者对选择性雌激素受体调节剂的研究现状进行综述。
Bibliography:31-1685/R
DING Hao , YANG Fan , CAI Yi , CHAI Xiaoyun , WU Qiuye (1. Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China; 2. School of Pharmacy, Yantai University, Yantai 264005, China)
estrogen;estrogen receptor;selectlve estrogen receptor modulators
Breast cancer has become the main malignant tumors which pose a serious threat to women's health. Selective estrogen receptor modulators, which served as the effective drug treatment, have been attracting more attention. Present re- search progress on the selective estrogen receptor modulators was summarized in this paper.
ISSN:1006-0111
DOI:10.3969/j.issn.1006-0111.2016.01.001